Skip to main content

and
  1. No Access

    Article

    Prevalence and determinants of shared decision-making for PSA testing in the United States

    Shared decision-making (SDM) is recommended for prostate-specific antigen (PSA) testing but appears underutilized. This population-based study assessed the prevalence and determinants of SDM for PSA testing am...

    Naeem Bhojani, Larry E. Miller, Kevin C. Zorn in Prostate Cancer and Prostatic Diseases (2024)

  2. No Access

    Article

    Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation

    Benign prostatic hyperplasia (BPH) is one of the most common diseases affecting men and can present with bothersome lower urinary tract symptoms (LUTS). Historically, transurethral resection of the prostate (T...

    David-Dan Nguyen, Tiange Li, Roseanne Ferreira in Prostate Cancer and Prostatic Diseases (2024)

  3. No Access

    Article

    Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study

    Recently, minimally invasive therapies (MITs), such as water vapor thermal therapy (WVTT) and prostatic urethral lift (PUL) have become an alternative to surgery or pharmacotherapy to manage benign prostatic h...

    Yeva Sahakyan, Aysegul Erman, Naeem Bhojani in Prostate Cancer and Prostatic Diseases (2023)